<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Transplant Proc</journal-id>
      <journal-title-group>
        <journal-title>Transplantation Proceedings</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0041-1345</issn>
      <issn pub-type="epub">1873-2623</issn>
      <publisher>
        <publisher-name>Elsevier Science Inc</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3202641</article-id>
      <article-id pub-id-type="pmid">21839214</article-id>
      <article-id pub-id-type="publisher-id">TPS23115</article-id>
      <article-id pub-id-type="doi">10.1016/j.transproceed.2011.06.050</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Regulatory T Cells in Transplantation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wood</surname>
            <given-names>K.J.</given-names>
          </name>
          <email>kathryn.wood@nds.ox.ac.uk</email>
          <xref rid="cor1" ref-type="corresp">⁎</xref>
        </contrib>
      </contrib-group>
      <aff>Transplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom</aff>
      <author-notes>
        <corresp id="cor1"><label>⁎</label>Address reprint requests to Kathryn J. Wood, Transplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom <email>kathryn.wood@nds.ox.ac.uk</email></corresp>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the
							<pub-date pub-type="ppub"/>. -->
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <volume>43</volume>
      <issue>6</issue>
      <fpage>2135</fpage>
      <lpage>2136</lpage>
      <permissions>
        <copyright-statement>© 2011 Elsevier Inc.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <copyright-holder>Elsevier Inc.</copyright-holder>
        <license>
          <license-p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>T Regulatory cells (Treg) play an important role in the induction and maintenance of immunological tolerance to self and alloantigens. Recent findings in experimental transplant models have demonstrated that Treg can control acute and delayed allograft rejection. Preclinical attempts to use Treg as a cellular therapy have been successfully undertaken demonstrating the safety and feasibility of such treatment, suggesting that they have therapeutic potential.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <p>Controlling the immune response to the allograft while retaining the ability to combat infection and prevent tumor formation presents major challenges. Immunosuppressive drugs are clearly very efficient at preventing acute rejection. However, current immunosuppressive therapies are much less effective at allowing the immune system to continue to respond to antigens other than donor alloantigens after transplantation, as they affect the function of all responding T cells irrespective of their antigen specificity.</p>
    <p>CD25<sup>+</sup>CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells are one of the key populations responsible for controlling immune responses to alloantigens and preventing rejection in vivo. Thymus derived or naturally occurring, CD25<sup>+</sup>CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells are generated as a distinct population during T cell development in the thymus.<xref rid="bib1 bib2 bib3 bib4" ref-type="bibr"><sup>1–4</sup></xref> Importantly for transplantation, CD25<sup>+</sup>CD4<sup>+</sup>FOXP3<sup>+</sup> regulatory T cells that are phenotypically and functionally similar to the thymus derived population can also be generated or induced after alloantigen exposure both in vivo<xref rid="bib5 bib6 bib7 bib8 bib9 bib10" ref-type="bibr"><sup>5–10</sup></xref> and ex vivo (for example <xref rid="bib11 bib12 bib13 bib14" ref-type="bibr"><sup>11–14</sup></xref>). We have shown, firstly, that regulatory T cells responsive to alloantigen can arise by both expansion of thymus derived or naturally occurring regulatory T cells and conversion following exposure to alloantigen, and secondly, that T cells in the periphery that are uncommitted to any lineage can be induced to acquire regulatory function, emphasizing the plasticity of T cell differentiation following activation.<xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> In each of these populations of regulatory T cells, sustained expression of FOXP3 is essential for maintaining the transcriptional programme established during their commitment to become a regulatory T cell.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref></p>
    <p>In a transplant recipient, donor alloantigen–reactive regulatory T cells may develop and their activity be sustained in a number of different ways. Although alloantigen pretreatment can induce and/or expand alloantigen reactive regulatory T cells, as discussed above,<xref rid="bib5 bib8" ref-type="bibr"><sup>5,8</sup></xref> arguably a more important source of antigen is the graft itself, as the immune system of a transplant recipient is constantly exposed to donor alloantigens while the graft continues to function. In a mouse model, we demonstrated that the presence of the allograft as the source of donor alloantigen was essential for maintaining the unresponsive state.<xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> This source of antigen is unique to transplantation and may be important in enabling FOXP3 expression to be stabilized and sustained and/or for regulatory T cells populations to be renewed in vivo throughout the posttransplant course,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> thereby allowing rejection to be controlled.</p>
    <p>Alloantigen induced regulatory T cells can prevent acute, as well as delayed or chronic graft rejection. In mouse models, our own laboratory has demonstrated that regulatory T cells induced in response to alloantigen in vivo can prevent the rejection of heart allografts in naïve mice with an intact immune repertoire,<xref rid="bib5 bib19" ref-type="bibr"><sup>5,19</sup></xref> as well as of heart, skin, and islet allografts in more subtle adoptive transfer models using immunodificient hosts that enable the mechanisms of suppression to be investigated.<xref rid="bib6 bib8 bib13" ref-type="bibr"><sup>6,8,13</sup></xref> Moreover, these same populations of alloantigen reactive regulatory T cells can prevent the development of transplant arteriosclerosis in mouse and humanized mouse models,<xref rid="bib20 bib21 bib22 bib23" ref-type="bibr"><sup>20–23</sup></xref> a feature of allograft rejection that is especially hard to control by experimental tolerance induction strategies<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> and immunosuppressive drug therapy.</p>
    <p>The specificity of alloantigen reactive regulatory T cells generated following antigen exposure has been investigated in a number of different experimental systems. Our own data suggest that in vivo, in mice with long-term surviving allografts, regulatory T cells respond to alloantigen predominantly via the indirect pathway of allorecognition.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref></p>
    <p>Understanding where regulatory T cells function to control rejection at different stages of the immune response after transplantation is critically important, not least for defining assays that can be used to assess whether regulatory T cells are contributing to graft survival in clinical transplantation. In experimental models, the draining lymphoid tissue has been shown to be the primary, initial site of interaction between regulatory T cells and naïve T cells.<xref rid="bib25 bib26 bib27 bib28" ref-type="bibr"><sup>25–28</sup></xref> Later on, regulation also manifests itself within the allograft.<xref rid="bib25 bib28" ref-type="bibr"><sup>25,28</sup></xref> Indeed, there are sufficient regulatory T cells present at some graft sites to enable them to control rejection when the graft is transferred to a fresh recipient.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> In clinical transplantation, evidence has been obtained that T cells with the phenotypic characteristics of regulatory cells are detectable in both the peripheral blood<xref rid="bib29 bib30" ref-type="bibr"><sup>29,30</sup></xref> and within the graft.<xref rid="bib31 bib32" ref-type="bibr"><sup>31,32</sup></xref></p>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakaguchi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Asano</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25): Breakdown of a single mechanism of self tolerance causes various autoimmune diseases</article-title>
          <source>J Immunol</source>
          <volume>155</volume>
          <year>1995</year>
          <fpage>1151</fpage>
          <pub-id pub-id-type="pmid">7636184</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Suri-Payer</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Amar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Thornton</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Shevach</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>CD4<sup>+</sup>CD25<sup>+</sup> T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells</article-title>
          <source>J Immunol</source>
          <volume>160</volume>
          <year>1998</year>
          <fpage>1212</fpage>
          <pub-id pub-id-type="pmid">9570536</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baecher-Allan</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Freeman</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hafler</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>CD4<sup>+</sup>CD25<sup>+</sup> high regulatory cells in human peripheral blood</article-title>
          <source>J Immunol</source>
          <volume>167</volume>
          <year>2001</year>
          <fpage>1245</fpage>
          <pub-id pub-id-type="pmid">11466340</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stephens</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Mottet</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mason</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Powrie</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro</article-title>
          <source>Eur J Immunol</source>
          <volume>31</volume>
          <year>2001</year>
          <fpage>1247</fpage>
          <pub-id pub-id-type="pmid">11298351</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bushell</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Transplantation tolerance induced by antigen pretreatment and depleting anti-CD4 antibody depends on CD4<sup>+</sup> T cell regulation during the induction phase of the response</article-title>
          <source>Eur J Immunol</source>
          <volume>25</volume>
          <year>1995</year>
          <fpage>2643</fpage>
          <pub-id pub-id-type="pmid">7589139</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hara</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kingsley</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Niimi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo</article-title>
          <source>J Immunol</source>
          <volume>166</volume>
          <year>2001</year>
          <fpage>3789</fpage>
          <pub-id pub-id-type="pmid">11238621</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorstenson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Khoruts</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Generation of anergic and potentially immunoregulatory CD25+CD4+ T cells in vivo after induction of peripheral tolerance with intravenous oral antigen</article-title>
          <source>J Immunol</source>
          <volume>167</volume>
          <year>2001</year>
          <fpage>188</fpage>
          <pub-id pub-id-type="pmid">11418648</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kingsley</surname>
              <given-names>C.I.</given-names>
            </name>
            <name>
              <surname>Karim</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bushell</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>CD25+CD4+ Regulatory T cells prevent graft rejection: CTLA-4– and IL-10–dependent immunoregulation of alloresponses</article-title>
          <source>J Immunol</source>
          <volume>168</volume>
          <year>2002</year>
          <fpage>1080</fpage>
          <pub-id pub-id-type="pmid">11801641</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Apostolou</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>von Boehmer</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>In vivo instruction of suppressor commitment in naive T cells</article-title>
          <source>J Exp Med</source>
          <volume>199</volume>
          <year>2004</year>
          <fpage>1401</fpage>
          <pub-id pub-id-type="pmid">15148338</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cobbold</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Castejon</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants</article-title>
          <source>J Immunol</source>
          <volume>172</volume>
          <year>2004</year>
          <fpage>6003</fpage>
          <pub-id pub-id-type="pmid">15128783</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marangoni</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Trifari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Scaramuzza</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>WASP regulates suppressor activity of human and murine CD4+CD25+FOXP3+ natural regulatory T cells</article-title>
          <source>J Exp Med</source>
          <volume>204</volume>
          <year>2007</year>
          <fpage>369</fpage>
          <pub-id pub-id-type="pmid">17296785</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oliveira</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Sawitzki</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Chapman</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Anti-CD4–mediated selection of Treg in vitro—in vitro suppression does not predict in vivo capacity to prevent graft rejection</article-title>
          <source>Eur J Immunol</source>
          <volume>38</volume>
          <year>2008</year>
          <fpage>1677</fpage>
          <pub-id pub-id-type="pmid">18465768</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Bushell</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy</article-title>
          <source>Transplanation</source>
          <volume>86</volume>
          <year>2008</year>
          <fpage>578</fpage>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Feng</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Strom</surname>
              <given-names>T.B.</given-names>
            </name>
            <name>
              <surname>Oukka</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Exogenous IFN-γ ex vivo shapes the alloreactive T-cell repertoire by inhibition of Th17 responses and generation of functional Foxp3+ regulatory T cells</article-title>
          <source>Eur J Immunol</source>
          <volume>38</volume>
          <year>2008</year>
          <fpage>2512</fpage>
          <pub-id pub-id-type="pmid">18792404</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>R.S.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Tha-In</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Induction of transplantation tolerance converts potential effector T cells into graft protective regulatory T cells</article-title>
          <source>Eur J Immunol</source>
          <volume>41</volume>
          <year>2011</year>
          <fpage>726</fpage>
          <pub-id pub-id-type="pmid">21243638</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Rudensky</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3</article-title>
          <source>Nat Immunol</source>
          <year>2007</year>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hamano</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Rawsthorne</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bushell</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for the maintenance of tolerance to alloantigen in anti-CD4 treated recipients</article-title>
          <source>Transplantation</source>
          <volume>62</volume>
          <year>1996</year>
          <fpage>856</fpage>
          <pub-id pub-id-type="pmid">8824489</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cobbold</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Pope</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>“Infectious” transplantation tolerance</article-title>
          <source>Science</source>
          <volume>259</volume>
          <year>1993</year>
          <fpage>974</fpage>
          <pub-id pub-id-type="pmid">8094901</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bushell</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function</article-title>
          <source>Am J Transplant</source>
          <volume>7</volume>
          <year>2007</year>
          <fpage>759</fpage>
          <pub-id pub-id-type="pmid">17391121</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warnecke</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bushell</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nadig</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of transplant arteriosclerosis by CD25+CD4+ T cells generated to alloantigen in vivo</article-title>
          <source>Transplantation</source>
          <volume>83</volume>
          <year>2007</year>
          <fpage>1459</fpage>
          <pub-id pub-id-type="pmid">17565319</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warnecke</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>CD4+ regulatory T cells generated in vitro with IFN-γ and allogeneic APC inhibit transplant arteriosclerosis</article-title>
          <source>Am J Pathol</source>
          <volume>177</volume>
          <year>2010</year>
          <fpage>464</fpage>
          <pub-id pub-id-type="pmid">20472892</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nadig</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Wieckiewicz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>In vivo prevention of transplant arteriosclerosis by ex vivo–expanded human regulatory T cells</article-title>
          <source>Nat Med</source>
          <volume>16</volume>
          <year>2010</year>
          <fpage>809</fpage>
          <pub-id pub-id-type="pmid">20473306</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Issa</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Hester</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Ex vivo–expanded human regulatory T cells prevent the rejection of skin allografts in a humanised mouse model</article-title>
          <source>Transplantation</source>
          <volume>90</volume>
          <year>2010</year>
          <fpage>1321</fpage>
          <pub-id pub-id-type="pmid">21048528</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koshiba</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Kitade</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>van Damme</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Regulatory cell–mediated tolerance does not protect against chronic rejection</article-title>
          <source>Transplantation</source>
          <volume>76</volume>
          <year>2003</year>
          <fpage>588</fpage>
          <pub-id pub-id-type="pmid">12923449</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Graca</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Cobbold</surname>
              <given-names>S.P.</given-names>
            </name>
            <name>
              <surname>Waldmann</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Identification of regulatory T cells in tolerated allografts</article-title>
          <source>J Exp Med</source>
          <volume>195</volume>
          <year>2002</year>
          <fpage>1641</fpage>
          <pub-id pub-id-type="pmid">12070291</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Adams</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tooley</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice</article-title>
          <source>Nat Immunol</source>
          <volume>7</volume>
          <year>2006</year>
          <fpage>83</fpage>
          <pub-id pub-id-type="pmid">16311599</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mempel</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Pittet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Khazaie</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation</article-title>
          <source>Immunity</source>
          <volume>25</volume>
          <year>2006</year>
          <fpage>129</fpage>
          <pub-id pub-id-type="pmid">16860762</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carvalho-Gaspar</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells</article-title>
          <source>J Immunol</source>
          <volume>180</volume>
          <year>2008</year>
          <fpage>6640</fpage>
          <pub-id pub-id-type="pmid">18453583</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Koshiba</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Yoshizawa</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation</article-title>
          <source>Am J Transplant</source>
          <volume>4</volume>
          <year>2004</year>
          <fpage>2118</fpage>
          <pub-id pub-id-type="pmid">15575917</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients</article-title>
          <source>Transpl Int</source>
          <volume>21</volume>
          <year>2008</year>
          <fpage>65</fpage>
          <pub-id pub-id-type="pmid">17887959</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients</article-title>
          <source>Transplantation</source>
          <volume>86</volume>
          <year>2008</year>
          <fpage>1837</fpage>
          <pub-id pub-id-type="pmid">19104431</pub-id>
        </element-citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dijke</surname>
              <given-names>I.E.</given-names>
            </name>
            <name>
              <surname>Velthuis</surname>
              <given-names>J.H.L.</given-names>
            </name>
            <name>
              <surname>Caliskan</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients</article-title>
          <source>Transplantation</source>
          <volume>83</volume>
          <year>2007</year>
          <fpage>1477</fpage>
          <pub-id pub-id-type="pmid">17565321</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>